Cargando…

Safety and tolerability of antipsychotics: focus on amisulpride

The introduction of the atypical antipsychotic drugs represents an important advance in the treatment of schizophrenia, because the therapeutic efficacy, tolerability, and safety profiles of these agents seem to be superior to that of the classical neuroleptics. As would be predicted from the pharma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juruena, Mario F, de Sena, Eduardo Pondé, de Oliveira, Irismar Reis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108712/ https://www.ncbi.nlm.nih.gov/pubmed/21701632 http://dx.doi.org/10.2147/DHPS.S6226

Ejemplares similares

Antipsychotic agents: efficacy and safety in schizophrenia
por: de Araújo, Arão Nogueira, et al.
Publicado: (2012)

Sertindole in the Management of Schizophrenia
por: Juruena, Mario F., et al.
Publicado: (2011)

Priapism secondary to antipsychotic treatments with favorable response to amisulpride
por: Pérez Balaguer, A., et al.
Publicado: (2022)

Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis
por: Papadopoulou, Dimitra, et al.
Publicado: (2023)

Temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper
por: de Araújo, Arão Nogueira, et al.
Publicado: (2014)

Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Mortimer, Ann M
Publicado: (2009)

Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study
por: Kim, Yongmin, et al.
Publicado: (2016)

Hyperprolactinaemia with amisulpride
por: Raj, Rajnish, et al.
Publicado: (2008)

The use of amisulpride in the treatment of acute psychosis
por: Nuss, Philippe, et al.
Publicado: (2007)

Amisulpride induced mania
por: Aggarwal, Ashish, et al.
Publicado: (2010)

Clinical Usefulness of Amisulpride Add-on Therapy in Schizophrenia Patients without Treatment Response to Second-generation Antipsychotics
por: Kang, Seung-Gul, et al.
Publicado: (2021)

Amisulpride Reexposure and Tardive Dyskinesia
por: Sidana, Ajeet
Publicado: (2018)

Delayed-onset akathisia due to amisulpride
por: Atmaca, Murad, et al.
Publicado: (2011)

Treatment of Burning Mouth Syndrome With Amisulpride
por: Rodriguez-Cerdeira, Carmen, et al.
Publicado: (2012)

Tardive dyskinesia with low dose amisulpride
por: Tharoor, Hema, et al.
Publicado: (2013)

An interview with Irismar Reis de Oliveira, Section Editor for Clinical Psychology and Psychotherapy
por: de Oliveira, Irismar Reis
Publicado: (2013)

The use of amisulpride in schizophrenic patients with resistant symptomatology
por: Kalfas, Dimitrios, et al.
Publicado: (2010)

Ejaculatory dysfunction associated with low dose amisulpride
por: Nagapurkar, Umesh, et al.
Publicado: (2013)

Extrapyramidal side effects with low doses of amisulpride
por: Mandal, Nikhiles, et al.
Publicado: (2014)

Amisulpride withdrawal dyskinesia: a case report
por: Lo, Yu-Chi, et al.
Publicado: (2017)

Pharmacogenomics: A focus on antidepressants and atypical antipsychotics
por: Lister, Jonathan F.
Publicado: (2016)

Augmenting amisulpride with clozapine had led to unmasking of akathisia
por: Ray, Anirban, et al.
Publicado: (2012)

Amisulpride Augmentation for Clozapine-Refractory Positive Symptoms: Additional Benefit in Reducing Hypersialorrhea
por: Bogorni, Fabiani, et al.
Publicado: (2015)

Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders
por: de Haan, Lieuwe, et al.
Publicado: (2023)

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
por: Solmi, Marco, et al.
Publicado: (2017)

Is amisulpride associated less with neuroleptic malignant syndrome? Review and hypothesis
por: Peritogiannis, Vaios, et al.
Publicado: (2010)

Metabolism and Excretion of Intravenous, Radio-Labeled Amisulpride in Healthy, Adult Volunteers
por: Fox, Gabriel M, et al.
Publicado: (2019)

Analysis of Amisulpride in Human Plasma by SPE and LC with Fluorescence Detection
por: Kudris, Illia V., et al.
Publicado: (2011)

Pulmonary Embolism Related to Amisulpride Treatment: A Case Report
por: Skokou, Maria, et al.
Publicado: (2013)

PM391. THE USE OF AMISULPRIDE IN TREATMENT OF PATIENTS WITH RESIDUAL SCHIZOPHRENIA
por: Janjic, Vladimir, et al.
Publicado: (2016)

A cost-utility analysis of Amisulpride and Paliperidone in the treatment of Schizophrenia
por: Abdall-Razak, Ali, et al.
Publicado: (2019)

Metformin in the Treatment of Amisulpride-Induced Hyperprolactinemia: A Clinical Trial
por: Zhu, Cuifang, et al.
Publicado: (2022)

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
por: Caruso, Giuseppe, et al.
Publicado: (2020)

Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis
por: Zangani, Caroline, et al.
Publicado: (2021)

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE
por: Drosos, Petros, et al.
Publicado: (2020)

Title- Augmenting Amisulpride With Clozapine Leading To Akathisia: A Case Report
Publicado: (2022)

Antipsychotic treatments; focus on lurasidone
por: Sumiyoshi, Tomiki
Publicado: (2013)

Antipsychotic Benzamides Amisulpride and LB-102 Display Polypharmacy as Racemates, S Enantiomers Engage Receptors D(2) and D(3), while R Enantiomers Engage 5-HT(7)
por: Grattan, Vincent, et al.
Publicado: (2019)

New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin
por: Caraci, Filippo, et al.
Publicado: (2020)

Contribution of Transcranial Direct Current Stimulation on Inhibitory Control to Assess the Neurobiological Aspects of Attention Deficit Hyperactivity Disorder: Randomized Controlled Trial
por: Cosmo, Camila, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_50gjo0a535bvoqcd027dmj8gv9